London-based medical device company Smith & Nephew is buying Texas-based Healthpoint Biotherapeutics for $782 million, according to the Washington Post. Healthpoint focuses on acute, chronic and burn-related wound care. The company hopes the acquisition will strengthen Smith & Nephew's position in bioactive wound care.
Healthpoint and its 460 employees will continue to be based in Fort Worth.
More Articles on Devices:
Symmetry Surgical to Partner With Italian Device Maker Biocommerciale
Ulrich Releases Posterior Spine Stabilization Implant
Bioventus Leases $5M Office, Creates 44 Jobs
Healthpoint and its 460 employees will continue to be based in Fort Worth.
More Articles on Devices:
Symmetry Surgical to Partner With Italian Device Maker Biocommerciale
Ulrich Releases Posterior Spine Stabilization Implant
Bioventus Leases $5M Office, Creates 44 Jobs